Reven

Reven is a biopharmaceutical company at the development stage, dedicated to developing and marketing appropriate solutions for cardiovascular and metabolism-related diseases. It has now begun utilizing RJX technology to provide care services for patients with limited treatment options (RJX is a fixed-combination intravenous (IV) drug therapy technology platform), offering multiple mechanisms of action to address various unmet medical needs.